supp.fit

Arachidonic Acid and Docosahexaenoic Acid: study protocols

27 study groups took Arachidonic Acid together with Docosahexaenoic Acid. These are the doses the studies gave. They are not a recommendation.

Arachidonic Acid: what the research found →

Dose per serving from research: Arachidonic Acid

15 study groups in 12 studies say how much Arachidonic Acid participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 100 mg to 250 mg, 67% of 15 study groups.

Daily doseStudy groups
100 mg to 250 mg
10
250 mg to 500 mg
2
500 mg to 1 g
1
1 g to 2.5 g
1
2.5 g to 5 g
1

Dose per serving from research: Docosahexaenoic Acid

15 study groups in 12 studies say how much Docosahexaenoic Acid participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 100 mg to 250 mg and 250 mg to 500 mg, 33% of 15 study groups each.

Daily doseStudy groups
100 mg to 250 mg
5
250 mg to 500 mg
5
500 mg to 1 g
3
1 g to 2.5 g
1
over 2.5 g
1

Commonly used together

7 of 27 study groups took Arachidonic Acid and Docosahexaenoic Acid with something else, but nothing that 3 or more different studies gave.

27 study groups

Study
Effect of Enteral Lipid Supplement on Severe Retinopathy of Prematurity: A Randomized Clinical Trial
2021 · AA:DHA group · Extremely preterm infants born before 28 weeks’ gestational age
100 mg/kg50 mg/kg92 days101
Platelet characteristics in extremely preterm infants after fatty acid supplementation: a randomized controlled trial
2025 · AA/DHA supplement · Extremely preterm infants born before 28 weeks’ gestational age
100 mg/kg50 mg/kg—84
Enteral supplementation with arachidonic and docosahexaenoic acid and pulmonary outcome in extremely preterm infants
2024 · AA and DHA supplementation · Extremely preterm infants
100 mg/kg50 mg/kg——
Docosahexaenoic Acid and Arachidonic Acid Supplementation and Sleep in Toddlers Born Preterm: Secondary Analysis of a Randomized Clinical Trial
2019 · DHA+AA supplementation · Children aged 10 to 16 months at enrollment, born before 35 weeks' gestation
200 mg200 mg180 days193
Fatty Acid Supplementation and Socioemotional Outcomes: Secondary Analysis of a Randomized Trial
2020 · DHA + AA · Children aged 10 to 16 months at enrollment, born at less than 35 weeks' gestation
200 mg200 mg180 days161
Evaluation of the Retinopathy of Prematurity Activity Scale (ROP-ActS) in a randomised controlled trial aiming for prevention of severe ROP: a substudy of the Mega Donna Mega trial
2022 · AA:DHA · Infants born before 28 weeks of gestational age
100 mg/kg50 mg/kg—84
Developmental Outcomes at 24 Months of Age in Toddlers Supplemented with Arachidonic Acid and Docosahexaenoic Acid: Results of a Double Blind Randomized, Controlled Trial
2017 · DHA/ARA supplement group · Healthy term-born toddlers enrolled at 12–14 months of age
200 mg200 mg1 year68
Long-chain Polyunsaturated Fatty Acid Supplementation Improves Mood in Elderly Japanese Men
2017 · LCPUFA group · Japanese men aged 55–64 years
120 mg300 mg4 weeks51
Effects of combining exercise with long-chain polyunsaturated fatty acid supplementation on cognitive function in the elderly: a randomised controlled trial
2020 · Ex + LCPUFA · Japanese adults aged 60–79 who were not exercising regularly, had age-related cognitive-decline complaints and lower memory scores, and did not have dementia; exercise arm participants had low skeletal muscle mass in the reported subgroup analysis
120 mg300 mg24 weeks21
Low Doses of Long-chain Polyunsaturated Fatty Acids Affect Cognitive Function in Elderly Japanese Men: A Randomized Controlled Trial
2015 · LCPUFA group · Japanese men aged 55–64 years without dementia
120 mg300 mg4 weeks—
Effect of arachidonic and docosahexaenoic acid supplementation on respiratory outcomes and neonatal morbidities in preterm infants
2023 · intervention · Very preterm infants with gestational age less than 29 weeks
100 mg/kg50 mg/kg——
Effect of arachidonic and docosahexaenoic acid supplementation on quality of growth in preterm infants: A secondary analysis of a randomized controlled trial
2023 · ARA:DHA group · Infants born before 29 weeks of gestation
100 mg/kg50 mg/kg——
Effects of Long-Chain Polyunsaturated Fatty Acids in Combination with Lutein and Zeaxanthin on Episodic Memory in Healthy Older Adults
2023 · LCPUFAs + LZ group, Trial 2 · Healthy Japanese adults aged 55–79 with memory complaints and no dementia; cognitive-decline subgroup had MoCA-J scores below 23
120 mg300 mg12 weeks96
Effects of Long-Chain Polyunsaturated Fatty Acids in Combination with Lutein and Zeaxanthin on Episodic Memory in Healthy Older Adults
2023 · LCPUFAs + LZ group, Trial 1 · Healthy Japanese adults aged 55–79 with memory complaints and no dementia; cognitive-decline subgroup had MoCA-J scores below 23
120 mg300 mg24 weeks40
The effect of supplementation with docosahexaenoic and arachidonic acid derived from single cell oils on plasma and erythrocyte fatty acids of pregnant women in the second trimester
2000 · intervention group · Healthy pregnant women in the second trimester
260 mg570 mg4 weeks12
Plasma fatty acid responses, metabolic effects, and safety of microalgal and fungal oils rich in arachidonic and docosahexaenoic acids in healthy adults
1996 · 1 x · healthy adult men
800 mg600 mg2 weeks8
Plasma fatty acid responses, metabolic effects, and safety of microalgal and fungal oils rich in arachidonic and docosahexaenoic acids in healthy adults
1996 · 3 x · healthy adult men
2.2 g1.7 g2 weeks8
Plasma fatty acid responses, metabolic effects, and safety of microalgal and fungal oils rich in arachidonic and docosahexaenoic acids in healthy adults
1996 · 5 x · healthy adult men
3.6 g2.9 g2 weeks8
Supplementation of arachidonic acid plus docosahexaenoic acid in cirrhotic patients awaiting liver transplantation: a preliminary study
2007 · AA/DHA group · Adults with end-stage liver disease awaiting liver transplantation
500 mg1 g6 weeks5
Human milk arachidonic acid and docosahexaenoic acid contents increase following supplementation during pregnancy and lactation
2009 · AA+DHA · Women supplemented during pregnancy and lactation
220 mg220 mg——
Modification of serum fatty acids in preterm infants by parenteral lipids and enteral docosahexaenoic acid/arachidonic acid: A secondary analysis of the Mega Donna Mega trial
2023 · AA:DHA supplementation group · Extremely preterm infants born before 28 weeks’ gestation
100 mg/kg50 mg/kg——
Proteomic Profile in Retinopathy of Prematurity: A Secondary Analysis of the Mega Donna Mega Randomized Clinical Trial
2026 · AA/DHA supplementation · Extremely preterm infants born before 28 weeks’ gestational age
100 mg/kg50 mg/kg—84
Essential Fatty Acid Supplementation and Early Inflammation in Preterm Infants: Secondary Analysis of a Randomized Clinical Trial
2023 · ARA:DHA group · Extremely preterm infants born at gestational age less than 29 weeks
100 mg/kg50 mg/kg—60
Arachidonic and docosahexaenoic acid supplementation and brain maturation in preterm infants; a double blind RCT
2024 · ARA:DHA group · Infants born before 29 weeks gestational age
100 mg/kg50 mg/kg—60
Urinary metabolite profiles in premature infants show early postnatal metabolic adaptation and maturation
2014 · intervention group · Premature infants with birth weight below 1500 g
60 mg/kg60 mg/kg4 weeks24
Fatty acid absorption in preterms on formulas with and without long-chain polyunsaturated fatty acids and in terms on formulas without these added
2001 · Group PB · Preterm newborns receiving preterm formula supplemented with arachidonic acid and docosahexaenoic acid
17 mg/kg10 mg/kg3 days13
Arachidonic acid and docosahexaenoic acid supplementation increases coronary flow velocity reserve in Japanese elderly individuals
2008 · PUFA · Japanese elderly individuals, mean age 65 years; no condition stated
240 mg240 mg90 days—
Arachidonic Acid and Docosahexaenoic Acid: study protocols | supp.fit